These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 28817295

  • 1. Does the offer of free prescriptions increase generic prescribing?
    Stuart B, Hendrick F, Dougherty JS, Xu J.
    Am J Manag Care; 2017 Jun 01; 23(6):e193-e201. PubMed ID: 28817295
    [Abstract] [Full Text] [Related]

  • 2. Impact of formulary restrictions on medication use and costs.
    Shen X, Stuart BC, Powers CA, Tom SE, Magder LS, Perfetto EM.
    Am J Manag Care; 2017 Aug 01; 23(8):e265-e274. PubMed ID: 29087150
    [Abstract] [Full Text] [Related]

  • 3. In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.
    Hoadley JF, Merrell K, Hargrave E, Summer L.
    Health Aff (Millwood); 2012 Oct 01; 31(10):2266-75. PubMed ID: 23048108
    [Abstract] [Full Text] [Related]

  • 4. How Low-Income Subsidy Recipients Respond to Medicare Part D Cost Sharing.
    Stuart B, Hendrick FB, Xu J, Dougherty JS.
    Health Serv Res; 2017 Jun 01; 52(3):1185-1206. PubMed ID: 27324201
    [Abstract] [Full Text] [Related]

  • 5. Encouraging generic use can yield significant savings.
    Zimmerman C.
    Find Brief; 2012 Nov 01; 15(8):1-3. PubMed ID: 23213854
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Effects of Cost Sharing on Adherence to Medications Prescribed for Concurrent Use: Do Definitions Matter?
    Sacks NC, Burgess JF, Cabral HJ, McDonnell ME, Pizer SD.
    J Manag Care Spec Pharm; 2015 Aug 01; 21(8):678-87. PubMed ID: 26233540
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS, Franklin JM, Avorn J, Landon J, Kesselheim AS.
    JAMA Intern Med; 2016 Jun 01; 176(6):763-8. PubMed ID: 27159336
    [Abstract] [Full Text] [Related]

  • 12. Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006.
    Li P, Schwartz JS, Doshi JA.
    J Am Heart Assoc; 2016 Nov 11; 5(11):. PubMed ID: 27836822
    [Abstract] [Full Text] [Related]

  • 13. Trends in Medicare Part D coverage of generics with equivalent brand-name drugs.
    Dusetzina SB, Cubanski J, Roberts AW, Hoadley J, True S, Nshuti L, Neuman T.
    Am J Manag Care; 2021 Jul 11; 27(7):283-288. PubMed ID: 34314117
    [Abstract] [Full Text] [Related]

  • 14. Zero copayment for generic statins could save billions.
    Manag Care; 2013 Mar 11; 22(3):44. PubMed ID: 23610806
    [No Abstract] [Full Text] [Related]

  • 15. Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications.
    Karaca-Mandic P, Swenson T, Abraham JM, Kane RL.
    Health Serv Res; 2013 Aug 11; 48(4):1311-33. PubMed ID: 23278369
    [Abstract] [Full Text] [Related]

  • 16. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC, McCoy LA, Thomas L, Peterson ED, Wang TY.
    Am Heart J; 2015 Jul 11; 170(1):55-61. PubMed ID: 26093864
    [Abstract] [Full Text] [Related]

  • 17. Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison.
    Gellad WF, Donohue JM, Zhao X, Mor MK, Thorpe CT, Smith J, Good CB, Fine MJ, Morden NE.
    Ann Intern Med; 2013 Jul 16; 159(2):105-14. PubMed ID: 23752663
    [Abstract] [Full Text] [Related]

  • 18. Evolutions in both co-payment and generic market share for common medication in the Belgian reference pricing system.
    Fraeyman J, Verbelen M, Hens N, Van Hal G, De Loof H, Beutels P.
    Appl Health Econ Health Policy; 2013 Oct 16; 11(5):543-52. PubMed ID: 24062144
    [Abstract] [Full Text] [Related]

  • 19. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
    Bazalo G, Weiss RC.
    Consult Pharm; 2012 Apr 16; 27(4):269-73. PubMed ID: 22498986
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.